Laurelcrest Capital Inc

Call
Website
12033 12th Ave NW
Seattle, WA 98177
+1 (206) 922-3634
https://laurelcrest.com

Laurelcrest Capital Inc is a global CBD solutions provider based in McMinnville, Oregon. They offer a wide range of bulk cannabinoid ingredients and finished products, all of which undergo rigorous third-party testing to ensure quality and compliance. With a commitment to sustainability and transparency, Laurelcrest is dedicated to providing customers with consistent, high-quality CBD solutions.

From THC-free oils to water-soluble products, Laurelcrest's offerings are designed in nature and scientifically perfected. Their products are sourced from select Oregon farms and are vegan, kosher, and allergen-free. With a team of experts and a focus on regulatory compliance, Laurelcrest is a trusted provider of CBD solutions worldwide.

Generated from the website

Own this business?
See a problem?

You might also like

Lazarus Naturals

Lazarus Naturals, based in Seattle, is a reputable producer of premium CBD oils, tinctures, and isolates. Their in-house production ensures quality control from plant to bottle. With a focus on transparency and purity, Lazarus Naturals offers CBD extracts that are trusted by consumers seeking high-quality products for their wellness needs. Generated from their website's infomation

James

Greenland is a Bellevue-based company with over 30 years of experience in herbal dietary supplements, specializing in their flagship product, Naturin2. This herbal tonic is thoughtfully crafted from a unique blend of selected botanical ingredients, drawing upon traditional Chinese healthcare science to support immunity, healthy digestion, and overall energy balance. Naturin2 is designed to be a convenient addition to daily wellness routines, featuring no preservatives, artificial ingredients, or added sugars. Each shot is rich in adaptogens and antioxidants, promoting a balanced body and a smooth, pleasant taste for easy consumption. Generated from the website

Svalinn Therapeutics, Inc

Svalinn Therapeutics, Inc., based in Seattle, WA, is focused on developing a safer radical cure for malaria, a disease that threatens 40% of the world's population. With an alarming statistic of 274,000 children under the age of five dying from malaria in 2019 alone, the company aims to address genetic barriers that hinder effective treatment for a significant portion of the affected population. The company is working on a modified therapeutic regime for Plasmodium vivax, which will enable all individuals, regardless of their enzyme status, to be cured of this disease. Svalinn Therapeutics is committed to ensuring that no one suffers lifelong recurrences of malaria or passes it on to others. Generated from the website
United States›Washington›Seattle›Laurelcrest Capital Inc

Partial Data by Infogroup (c) 2025. All rights reserved.